|
Price: $6.9700
$0.14 
2.050%
|
| Day's High:
| $7.03
| Week Perf:
| 0.87 %
|
| Day's Low: |
$ 6.85 |
30 Day Perf: |
34.3 % |
| Volume (M): |
25,544 |
52 Wk High: |
$ 7.09 |
| Volume (M$): |
$ 178,044 |
52 Wk Avg: |
$4.60 |
| Open: |
$6.85 |
52 Wk Low: |
$3.26 |
|
|
| Market Capitalization (Millions $) |
2,212 |
| Shares
Outstanding (Millions) |
317 |
| Employees |
8,248 |
| Revenues (TTM) (Millions $) |
- |
| Net Income (TTM) (Millions $) |
820 |
| Cash Flow (TTM) (Millions $) |
2,706 |
| Capital Exp. (TTM) (Millions $) |
0 |
Nu Holdings Ltd
| NU is expected to report next financial results on April 19, 2024. |
|
|
|
|
Customers Net Income fell by |
NU's Customers Net Profit Margin fell to |
-32.71 % |
13.91 %
|
|
|
|
|
|
|
|
| Stock Performances by Major Competitors |
|
|
|
|
Arch Therapeutics Inc
Arch Therapeutics Inc is a diversified company that operates in the medical technology industry. The company has been in operation for several years, and like most businesses, it has experienced both peaks and valleys in terms of financial performance.
However, the recent announcement of a disastrous fiscal span is quite concerning for investors, employees, and other stakeholders. According to the company's financial statement, the revenue for the fiscal year ending March 31, 2023, decreased by a staggering 98.34% to $0.02 million. In addition, the net deficit per share widened to $-0.71, which represents a significant decline from the previous year.
|
|
Greenwich Lifesciences Inc
Investors of the stock market can breathe a sigh of relief as the January to March 31 2023 reporting cycle resumes. The Diversified sector has seen a number of businesses report their numbers, which includes some exciting developments. One of them being the steady growth of GLSI, despite a disclosed operating deficit of $-2.241082 million for the most recent fiscal period.
Although the company has not yet disclosed its revenue, the numbers certainly reveal a positive shift in the business's long-term growth strategy. For context, let's compare the recent performance with the first quarter of 2021, where the company had an operating deficit of $1.620131 million. This comparison highlights the vital need for GLSI to prioritize the cultivation and growth of its business model early on, while also staying liquid in order to run day to day operations.
|
|
Cryomass Technologies Inc
In the first quarter of 2023, Cryomass Technologies Inc has shown a significant improvement in its operating deficit, which was $-1.531555 million. Although the company did not provide any top-line figures for the period from January to March 31, 2023, it is still a very positive outcome for market participants, particularly coming off the back of a $-2.12779 million operating deficit in the first quarter of 2022.
Despite the lack of top-line figures, Cryomass Technologies Inc has demonstrated its potential to become a leading industry player, with market confidence starting to grow. The company's losses have also decreased from $-2.152 million in the first quarter of 2022 to $-1.599 million in the same period this year, further reinforcing its potential for success.
|
|
Ambipar Emergency Response
Following bewildering Revenue improvement of 1231170.154 % year on year to $320.13 million in the most recent fiscal period, AMBIs' profitability turned positive at $0.14.
|
|
Klx Energy Services Holdings Inc
Klx Energy Services Holdings Inc. (KLXE) is a diversified company that provides services and solutions to the oil and gas industry in North America. The company's offerings include completion, intervention, and production services, as well as oilfield fluid management and logistics services. KLXE operates in two segments: Completion Services and Oilfield Services.
In the most recent fiscal period, KLXE's earnings turned positive, with a per-share earning of $0.65. This is a significant improvement compared to the previous year when the company had reported a loss of $1.98 per share. The company also reported revenue growth of 57.321% to $239.60 million, which is a milestone for the company. Sequentially, the company also saw a revenue advance of 7.3% from $223.30 million.
|
| Per Share |
Current |
| Earnings (TTM) |
2.58 $ |
| Revenues (TTM) |
-
|
| Cash Flow (TTM) |
8.52 $ |
| Cash |
13.14 $
|
| Book Value |
15.41 $
|
| Dividend (TTM) |
1.5 $ |
|
|
| Per Share |
|
| Earnings (TTM) |
2.58 $
|
| Revenues (TTM) |
- |
| Cash Flow (TTM) |
8.52 $ |
| Cash |
13.14 $
|
| Book Value |
15.41 $ |
| Dividend (TTM) |
1.5 $ |
|
|
| |
| Electric |
|
Segment |
|
 |
of total Revenue |
| Gas |
|
Segment |
|
|
of total Revenue |
| Transmission |
|
Segment |
|
|
of total Revenue |
| NU Enterprises |
|
Segment |
|
|
of total Revenue |
| Other |
|
Segment |
|
|
of total Revenue |
| |
| Nu Holdings Ltd's Operating Statistics
|
Decrease / Increase
|
| |
|
|
|
| Residential electric sales (GWh) |
|
 |
|
| Commercial electric sales (GWh) |
|
|
|
| Industrial electric sales (GWh) |
|
|
|
| Other electric sales (GWh) |
|
|
 |
| Total electric sales (GWh) |
|
|
|
| Residential natural gas sales (Bcf) |
|
|
|
| Commercial natural gas sales (Bcf) |
|
|
|
| Industrial natural gas sales (Bcf) |
|
|
|
| Other natural gas sales (Bcf) |
|
|
|
| Total natural gas sales (Bcf) |
|
|
|
|
|
5.79% 